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CD8+ T-cell response is critical in the pathogenesis of cerebral malaria during
blood-stage. Our group and other have been shown that angiotensin II (Ang II) and
its receptor AT1 (AT1R), a key effector axis of renin-angiotensin system (RAS), have
immune regulatory effects on T cells. Previously, we showed that inhibition of AT1R
signaling protects mice against the lethal disease induced by Plasmodium berghei ANKA
infection However, most of the Ang II/AT1R actions were characterized by using only
pharmacological approaches, the effects of which may not always be due to a specific
receptor blockade. In addition, the mechanisms of action of the AT1R in inducing the
pathogenic activity of Plasmodium-specific CD8+ T cells during blood-stage were not
determined. Here, we examined how angiotensin II/AT1R axis promotes the harmful
response of Plasmodium-specific CD8+ T-cell during blood-stage by using genetic and
pharmacological approaches.We evaluated the response of wild-type (WT) and AT1R
−/−
Plasmodium-specific CD8+ T cells in mice infected with a transgenic PbA lineage
expressing ovalbumin; and in parallel infected mice receiving WT Plasmodium-specific
CD8+ T cells were treated with losartan (AT1R antagonist) or captopril (ACE inhibitor).
Both, AT1R
−/− OT-I cells and WT OT-I cells from losartan- or captopril-treated mice
showed lower expansion, reduced IL-2 production and IL-2Rα expression, lower
activation (lower expression of CD69, CD44 and CD160) and lower exhaustion profiles.
AT1R
−/− OT-I cells also exhibit lower expression of the integrin LFA-1 and the chemokine
receptors CCR5 and CXCR3, known to play a key role in the development of cerebral
malaria. Moreover, AT1R
−/− OT-I cells produce lower amounts of IFN-γ and TNF-α and
show lower degranulation upon restimulation. In conclusion, our results show the pivotal
mechanisms of AT1R-induced harmful phenotype of Plasmodium-specific CD8
+ T cells
during blood-stage malaria.
Keywords: angiotensin, AT1 receptor, CD8
+ T cells, blood-stage, malaria
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INTRODUCTION
Malaria is still a major global public health problem with
207 million cases resulting in more than 400,000 deaths
annually (Murray et al., 2012; World Health Organization,
2015). The most severe complication, termed cerebral malaria
(CM), a neuropathology induced primarily by Plasmodium
falciparum, is the main cause of death in human malaria
(Murray et al., 2012; World Health Organization, 2015).
Current therapeutic strategies of CM are limited to anti-
parasitic drugs, typically administered late during infection.
These pharmacological interventions lack efficacy in many cases,
and the mortality rate of CM, even after treatment, remains
at 10–20% (Stockman, 2012; Oluwayemi et al., 2013). Better
understanding of the parasitological and immunological events
leading to the development of CM could aid in the development
of improved therapeutic options to treat the disease.
Multiple cell types, including monocytes, macrophages,
natural killer cells and CD8+ T cells are sequestered within the
brain at the onset of experimental CM (ECM) in mice. ECM is a
serious neurological syndrome that has many of the clinical and
pathological features of human CM in susceptible strains of mice
infected with Plasmodium berghei ANKA (PbA) (Amante et al.,
2010). In this regard, there is mounting evidence suggesting that
CD8+ T cells are the main effector cells in the development of
ECM (Boubou et al., 1999; Belnoue et al., 2002; Nitcheu et al.,
2003; Potter et al., 2006; Rénia et al., 2006; Suidan et al., 2008;
Hunt et al., 2010; Claser et al., 2011; Haque et al., 2011; Shaw et al.,
2015). Because of ethical limitations, it is difficult to determine
whether CD8+ T cells are involved in the pathogenesis of human
CM. But in a systematic post-mortem study of the brains of
Malawian children with CM, few CD8+ T cells were observed
intravascularly in distended capillaries (Dorovini-Zis et al., 2011),
which is not inconsistent with the PbA mouse model where the
relatively small numbers of sequestered CD8+ T cells are difficult
to observe by histology (Belnoue et al., 2002). Thus, the key role of
CD8+ T cells and other immune cells in human disease has been
a topic of heated debate. The cellular mechanisms implicated
in the damage to the blood–brain barrier seem to involve the
degranulation of Granzyme B, perforin, and proinflammatory
cytokines such as interferon-γ (IFN-γ), tumor necrosis factor-α
(TNF-α) and lymphotoxin-α (LT-α) (Grau et al., 1991; Engwerda
et al., 2002; Nitcheu et al., 2003; Potter et al., 2006; Suidan et al.,
2008; Claser et al., 2011; Haque et al., 2011). However, evidence of
the induction of CD8+ T cells specific to blood-stage Plasmodium
antigens was described only recently (Lau et al., 2011; Howland
et al., 2013). Because MHC I-restricted epitopes of Plasmodium
antigens during blood-stage malaria were not known, transgenic
lineages of parasites expressing model epitopes, for which T-cell
Abbreviations: Ang II, angiotensin II; ACE, angiotensin-converting enzyme;
CM, cerebral malaria; CTLA-4, cytotoxic T-lymphocyte-associated protein 4;
IFN-γ, interferon-γ; IL-2, interleukin-2; IL-2R, interleukin-2 receptor; IL7-Rα,
interleukin-7 receptor α chain; KLRG-1, killer cell lectin-like receptor G1; LAG-3,
lymphocyte-activation gene 3; LFA-1; Lymphocyte function-associated antigen 1;
LT-α, lymphotoxin-α; MFI, median fluorescence intensity; PD-1, programmed cell
death 1; p.i., post infection; RAS, renin-angiotensin system; TNF-α, tumor necrosis
factor-α; WT, wild-type.
receptor (TCR) transgenic mice are available, were generated to
study the immune response of antigen-specific CD8+ T cells
(Lundie et al., 2008;Miyakoda et al., 2008). These studies revealed
that antigens of blood-stage P. berghei parasites are captured and
cross-presented by CD8α+ dendritic cells to induce activation,
proliferation, and effector function of parasite-specific CD8+ T
cells (Miyakoda et al., 2008; Lundie et al., 2008). In addition, they
confirmed that parasite-specific cells are sequestered in the brain
and are pathogenic to the host by inducing CM (Lundie et al.,
2008; Miyakoda et al., 2008; Howland et al., 2015b). However,
the mechanisms that induce the pathogenic activity of parasite-
specific CD8+ T cells during the blood-stage of Plasmodium
infection remain poorly understood.
Angiotensin II (Ang II) is a renin–angiotensin system (RAS)
effector molecule, which exerts its actions via AT1 receptors
(AT1R) and AT2 receptors (AT2R), which have been reported
to mediate contrasting functions (Basso and Terragno, 2001).
Initially, it was thought that the main physiological role of
Ang II was to control blood pressure through the regulation
of vascular tonus and electrolytic balance (Basso and Terragno,
2001). However, studies have shifted the attention toward its
nonclassic effects, and Ang II has been proposed to be central
in the inflammatory aspects of different diseases (Bush et al.,
2000; Donadelli et al., 2000). Previously, our group and others
have demonstrated that T cells express a functional RAS that
produces and responds to Ang II mainly via AT1R (Kunertradek
et al., 1994; Nataraj et al., 1999; Inoue et al., 2006; Guzik et al.,
2007; Jurewicz et al., 2007; Hoch et al., 2008; Platten et al., 2009;
Silva-Filho et al., 2011, 2013, 2015, 2016; Zhang et al., 2012).
AT1R expression is upregulated in polyclonal T cells during the
blood-stage of PbA infection, and it stimulates the production
of perforin and migration/sequestration of polyclonal CD8+
T cells in the brain. In turn, CD8+ T cells promote cerebral
edema, cognitive impairment, and lethal disease (Silva-Filho
et al., 2011, 2013). In contrast, more recently, we showed that
AT1R signaling induces expansion but dampens the activation
and exhaustion of antigen-specific CD8+ T cells during the
effector response to whole-parasite immunization (Silva-Filho
et al., 2016). Also, effector cells lacking AT1R generate a higher
number of memory cells, which is an important factor to limit
parasite development in the liver (Silva-Filho et al., 2016). So, it
seems that the intrinsic role and function of AT1R in CD8
+ T
cells could be stage dependent, decreasing the protective response
during immunization with liver-stage parasites but stimulating
the harmful response during infection with blood-stage parasites.
Indeed, inhibition of AT1R only in Plasmodium-specific CD8
+ T
cells promoted better control of blood parasitemia and improved
survival of mice against the lethal disease induced by blood-stage
malaria (Silva-Filho et al., 2016). In agreement, pharmacological
blockade of AT1R protected mice against ECM and increased
survival (Silva-Filho et al., 2013; Gallego-Delgado et al., 2016).
Nonetheless, this study characterized the effects of AT1R during
PbA infection by using only pharmacological approaches, the
effects of which may not always be due to a specific receptor
blockade. Thus, there is no clear evidence whether the intrinsic
role of AT1R in CD8
+ T cells differs following immunization
vs. infection. Addressing this issue is important for better
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delineation of strategies targeting the AT1R to improve the
protective memory CD8+ T cells or to inhibit harmful pro-
inflammatory CD8+ T-cell responses.
Here, we examined the mechanisms of action of AT1R
specifically in the Plasmodium-specific CD8+ T-cell response
during blood-stage malaria, by using wild-type (WT; AT1R
+/+)
or AT1R
−/− CD8+ T cells from ovalbumin (OVA)-specific TCR
transgenic mice (OT-I), which allow the tracking of the antigen-
specific CD8+ T cell response (Lundie et al., 2008; Miyakoda
et al., 2008; Cockburn et al., 2010; Chen and Zavala, 2013;
Silva-Filho et al., 2016). In parallel, to complement the genetic
approach, we also tested the effects of two drugs that block
the AT1R response, losartan (AT1R antagonist) or captopril
(inhibitor of Ang II production), in mice that received WT OT-
I cells. For the infection, we used transgenic PbA expressing the
C-terminal fragment of OVA (amino acids 150–386) fused to the
N-terminus of PbA heat shock protein 70 (Miyakoda et al., 2008).
This region in the OVA comprehends the epitope SIINFEKL,
which allows the response of the SIINFEKL-specific CD8+ T
cell population (OT-I cells) to be monitored as the population
responding to the blood-stage Plasmodium antigen (Miyakoda
et al., 2008).
Our results revealed that blockage of AT1R by both genetic
and pharmacological tools impaired priming of Plasmodium-
specific CD8+ T cells, as observed by reduced expression of
activation markers such as CD69, CD160, and CD44. AT1R
promotes upregulation of interleukin-2 receptor α chain (IL-
2Rα) and interleukin-2 (IL-2) production, important for the
clonal expansion of antigen-specific CD8+ T cells. Moreover,
there is a reduction in the expression of the integrin LFA-
1 (CD11a), and the chemokine receptors CCR5 and CXCR3
in AT1R
−/− OT-I cells. The lack of AT1R signaling also
reduced exhaustion as observed by lower expression of
CTLA-4 and LAG-3. Consequently, AT1R inhibition decreased
cytokine production and degranulation by Plasmodium-specific
CD8+ T cells. Our results demonstrate that, different from
the effector response to whole parasite immunization, Ang
II, via AT1R, stimulates the Plasmodium-specific CD8
+ T-
cell response following infection with blood-stage malaria.
This brings new perspectives to the protective effect of
inhibition of AT1R (Silva-Filho et al., 2013, 2016; Gallego-
Delgado et al., 2016) and advances the knowledge of the
mechanisms involved in the pathogenic activity of parasite-
specific CD8+ T cells during blood-stage malaria. Moreover, it
adds novelty to the functions attributed to the RAS in malaria
pathogenesis.
MATERIALS AND METHODS
Mice
Six- to eight-week-old male C57BL/6 mice were used in all
experiments.WTC57BL/6mice (CD45.2+) were purchased from
NCI (Frederick, MD). OT-1 TCR transgenic mice (CD45.1+)
expressing the TCR specific for OVA257−264/K
b (SIINFEKL
peptide) were kindly provided by Dr. David Sacks (National
Institute of Allergy and Infectious Disease, Bethesda, MD).
AT1R
−/− mice (B6.129P2-Agtr1atm1Unc/J; backcrossed to
C57BL/6J for seven generations) were purchased from Jackson
Laboratory (Bar Harbor, ME).
All animal procedures followed previously described studies
(Overstreet et al., 2011; Silva-Filho et al., 2016). Mice that
had previously been backcrossed to the CD45.1 C57BL/6
background for more than 10 generations were used from our
colony. C57BL/6-Agtr1atm1Unc (CD45.1+) were crossed to OT-
I transgenic C57BL/6 mice and F1 progeny positive for the
TCR transgene were crossed back to C57BL/6-Agtr1atm1Unc mice
(CD45.1+) to obtain TCR transgenic mice homozygous for the
Agtr1atm1Unc targeted mutation (CD45.1+). Mice carrying the
transgenic TCR (OT-I) were phenotyped by flow cytometry
using fluorochrome-conjugated anti-mouse antibodies against
Vα2, CD45.1, and CD8. For genotyping, REDExtract-N-Amp
tissue PCR kits (Sigma) were used to extract the genomic DNA
from tail clippings following the manufacturer’s protocol. Primer
information and PCRs conditions were obtained following
the manufacturer’s protocol. Primer sequences were as follow:
oIMR0738 (WT forward), TGA GAA CAC CAA TAT CAC
TG; oIMR0739 (common), TTC GTA GAC AGG CTT GAG;
oIMR6218 (mutant forward), CCT TCT ATC GCC TTC TTG
ACG, yielding PCR products of 520 bp if mutant and 483
bp if WT, or both sizes if heterozygote. PCR was performed
with the following cycle settings: 94◦C for 3min; 94◦C for
30 s; 55◦C for 30 s for annealing; and 72◦C for elongation
for 1min (total of 35 cycles). All mice were housed, bred,
and maintained in the animal care facility at Johns Hopkins
University. The Institutional Animal Care and Use Committee
of Johns Hopkins University approved the experiments involving
mice.
Parasites
The transgenic P. berghei ANKA with truncated C-terminal
fragment of OVA (amino acids 150–386) fused to the N-terminal
sequence (amino acids 1–5) of the PbA heat shock protein 70
gene was used (Miyakoda et al., 2008). A cryopreserved sample
of transgenic P. berghei ANKA-infected erythrocytes was kindly
provided by Dr. Katsuyuki Yui, Nagasaki University, Nagasaki,
Japan. The sample was thawed and injected intraperitoneally into
a naive C57BL/6 mouse. Cells were maintained in mice up to
seven passages prior to use.
Adoptive Transfer, Infection, and
Treatments
For adoptive transfer, cell suspensions from the spleen of
WT (AT1R
+/+) and AT1R
−/− OT-I mice were prepared and
pooled. CD8+ T cells were purified by negative isolation using
magnetic beads according to the manufacturer’s instructions
(CD8a+ T cell isolation kit; Miltenyi Biotech, Paris, France).
We obtained >95% CD8+CD45.1+ T cell (OT-I) enrichments
and 104 purified naive WT or AT1R
−/− OT-I cells (CD45.1+)
were injected into the tail vein of WT C57BL/6 mice (CD45.2+).
After 24 h, the recipient mice were infected with OVA-PbA by
intraperitoneal injection of 5 × 106 infected red blood cells
(Figure 1A). In parallel, mice that received WT OT-I cells were
divided into three treatment groups: vehicle, or 20mg/kg/day
losartan, an AT1 receptor blocker, or 20 mg/kg/day captopril,
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FIGURE 1 | AT1R promotes upregulation of the IL-2Rα chain and IL-2 production in Plasmodium-specific CD8
+ T cells during PbA infection. AT1R
+/+
or AT1R
−/− OT-I cells (CD8+CD45.1+) recovered from the spleen of mice infected with OVA-PbA (CD45.2+) were analyzed at day 6 p.i. (A) Schematics of the
experimental design. 1 × 104 naive WT (AT1R
+/+) or AT1R
−/− OT-I cells (CD8+CD45.1+) were adoptively transferred to WT C57Bl/6 mice (CD45.2+) recipients 1
day before intraperitoneal injection of 5 × 106 infected red blood cells (RBCs) with P. berghei ANKA expressing ovalbumin (OVA-PbA). Mice were euthanized at the
indicated time point for recovery and analysis of OT-I cells. (B,C) Representative dot plots and percentage of CD25+ OT-I cells among total OT-I cells in the spleen on
day 6 p.i. (*p = 0.0006). (D) Expression levels of CD25 in OT-I cells at day 6 p.i. (*p = 0.0061). (E,F) IL-2 production by WT and AT1R
−/− OT-I cells was evaluated after
4-h ex vivo re-stimulation with cognate peptide at day 6 p.i. (*p = 0.0017). *In relation to WT OT-I cells. Data are means ± SEM of five mice per group and are pooled
from three independent experiments with similar results. The gating strategy used for the flow cytometry analysis is indicated in the Materials and Methods section.
an angiotensin-converting enzyme (Figure 2A). Treatments
began on the day of infection and were administered by
gavage daily for 6 days. The condition of the mice was
checked daily, and parasitemia was monitored by microscopic
examination of standard blood films. Mice were euthanized
at day 6 p.i., at the onset of signs of CM such as hemi- or
paraplegia, ataxia, deviation of the head, convulsions, and coma
(Martins et al., 2010; Haque et al., 2011; Silva-Filho et al.,
2013).
Lymphocyte Isolation
Spleens were collected on day 6 p.i. and single-cell suspensions
of lymphocytes were obtained as previously described
(Silva-Filho et al., 2016). All lymphocytes were prepared
and resuspended in DMEM supplemented with 10% heat-
inactivated fetal bovine serum (FBS), 50mM sodium
bicarbonate, 2mM glutamine, 100 U/ml penicillin, 100
µg/ml streptomycin, and 25mM HEPES. The numbers of
OT-I cells were determined by automated cell counting
using the Trypan blue dye exclusion method (viability >
95%) and flow cytometry with anti-CD45.1 and anti-CD8
antibodies.
Ex vivo Stimulation and Intracellular
Staining
El4 cells (T cell lymphoma cell line of C57/BL6 [H-2b] origin)
were pulsed or not with SIINFEKL peptide (10 µg/ml) at 37◦C
for approximately 1 h. Peptide-coated or control target cells
were washed three times and added to lymphocytes harvested
from the spleen of mice infected with OVA-PbA. The cells were
stimulated for 4 h at 37◦C in the presence of 1:400 brefeldin A
(GolgiPlug; BD Bioscience) and 1:600 monensin (GolgiStop; BD
Bioscience) and anti-CD107a-fluorescein isothiocyanate. Cells
were washed twice in cold medium before proceeding to surface
and intracellular staining. Intracellular staining was performed
using a Cytofix/Cytoperm kit (BD Biosciences) and stained
for intracellular cytokines (anti-IFN-γ-PE-Cy7, anti-TNF-α-
Pacific blue, and anti-IL-2-APC) according to the manufacturer’s
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FIGURE 2 | Losartan and captopril treatments reduce expansion of Plasmodium-specific CD8+ T cells and IL-2Rα-chain/IL-2 expression. WT OT-I cells
(CD8+CD45.1+) recovered from the spleen of mice infected with OVA-PbA (CD45.2+) treated with vehicle, losartan (20 mg/kg/day) or captopril (20 mg/kg/day) were
analyzed at day 6 p.i. (A) Schematics of the experimental design. 1 × 104 naive WT (AT1R
+/+) OT-I cells (CD8+CD45.1+) were adoptively transferred to WT C57Bl/6
mice (CD45.2+) recipients 1 day before intraperitoneal injection of 5 × 106 infected red blood cells (RBCs) with P. berghei ANKA expressing ovalbumin (OVA-PbA).
Mice were separated into three groups: (1) treated with vehicle, (2) treated with 20 mg/kg losartan, an AT1 receptor blocker, (3) treated with 20 mg/kg captopril, an
angiotensin-converting enzyme inhibitor. Mice were euthanized at the indicated time point for recovery and analysis of OT-I cells. (B) Total number of WT OT-I cells per
spleen at day 6 post infection in naive, vehicle-, losartan-, and captopril-treated mice infected with OVA-PbA, calculated as the frequencies obtained by
CD8+CD45.1+ staining, multiplied by the total number of cells obtained after spleen excision (*p < 0.0001 in relation to naive OT-I cells; #p < 0.0001 in relation to WT
OT-I cells from infected mice treated with vehicle). Data are means ± SEM of five mice per group and are representative of three independent experiments with similar
results. (C,D) Representative dot plots and percentage of CD25+ OT-I cells among total OT-I cells in the spleen on day 6 post infection (*p < 0.0001). (E) Expression
levels of CD25 in OT-I cells at day 6 post infection (*p < 0.0001). (F) IL-2 production by WT OT-I cells from the different groups was evaluated after 4-h ex-vivo
re-stimulation with cognate peptide at day 6 post infection (*p < 0.0001). *In relation to WT OT-I cells from infected mice treated with vehicle. Data are means ± SEM
of five mice per group and are pooled from three independent experiments with similar results. The gating strategy used for the flow cytometry analysis is indicated in
the Materials and Methods section.
protocol. Later, cells were washed and analyzed on an LSR II flow
cytometer (BD Bioscience).
Antibodies and Flow Cytometry
All antibodies were purchased from eBioscience or BD
unless stated otherwise. The following fluorochrome-conjugated
monoclonal antibodies were used: CD45.1 (A20); CD8 (53-
6.7), CD11a (M17/4), CD25 (PC61.5), CD69 (H1.2F3), CD44
(IM7), CD62L (MEL-14), CD107a (1D4B), CD160 (CNX46-
3), CCR5 (HM-CCR5-7A4), CTLA-4 (UC10-4B9), CXCR3
(CXCR3-173), LAG-3 (C9B7W), PD-1 (J43), IFN-γ (XMG1.2),
IL-2 (ES6-5H4), TNF-α (MP6-XT22). PerCP/PE/fluorescein
isothiocyanate-conjugated IgG1 and IgG2 isotype controls were
all purchased from BD Pharmingen. All results were collected
with CellQuest software on a FACSCalibur analyzer (Becton
Dickinson), and cytokine experiments were acquired on a LSRII
flow cytometer (Becton Dickinson). For flow cytometry, cells
were incubated with Fc block (anti-mouse CD16 and CD32
antibodies) to block non-specific binding sites for 30 min at 4◦C.
Later, the cells were washed and incubated with the appropriate
concentration of antibodies cited above. IgG isotypes were
used as irrelevant antibodies to define positive populations as
indicated in the gate strategy (Figure S1). At least 105 cells per
sample were acquired. Analysis was performed using FlowJo
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software (TreeStar). All data were collected and presented in a
log scale of fluorescence intensity and presented as plots. The
percentage of OT-I lymphocytes was determined in a gate of
CD8+CD45.1+ cells (Figure S1), and each analysis was made in
relation to the total OT-I cells (gated on CD8+CD45.1+ cells), as
showed in the gate strategy (Figure S1). The MFI was calculated
in the total OT-I cells (gated on CD8+CD45.1+ cells) considering
the fluorescence of the isotype control using the FlowJo software
(TreeStar) (Figure S1). Some analyses were also performed in the
non-OT-I CD8CD45.2 T cell endogenous population, gated on
CD8+CD45.1− cells (Figure S1).
Data Analysis
Each experiment was carried out using five animals per
group. Data are reported as the means ± SEM of three
representative and independent experiments with similar results.
For parametric distributions, checked by the Shapiro-Wilk test,
differences between the two groups (WT and AT1R
−/−) were
compared by a two-tailed Student’s t-test, or Mann–Whitney
test for non-parametric distributions. Differences between three
groups (vehicle, losartan, and captopril) were compared by
one-way analysis of variance, followed by the Newman–Keuls
post-test for parametric distributions, or by Kruskal-Wallis test
followed by the Dunn’s multiple comparison test for non-
parametric distributions. All testes were done using Prism 5
software (GraphPad Software, version 5). The level of significance
was set at α= 0.05.
RESULTS
AT1R Promotes Expansion of
Plasmodium-specific CD8+ T Cells during
Blood-Stage Malaria
Previously, we demonstrated that Ang II, via AT1R, acts as
a co-stimulatory signal for T-cell activation, promotes effector
function, adhesion, and migration of T cells to the brain during
blood-stage PbA infection (Silva-Filho et al., 2013). In addition,
AT1R in antigen-specific CD8
+ T cells regulates expansion,
differentiation, and function during effector and memory phases
of the response against immunization with radiation-attenuated
Plasmodium sporozoites (Silva-Filho et al., 2016). Here, to
determine if the absence of this receptor results in a difference
in the expansion of Plasmodium-specific CD8+ T cells during
infection with blood-stage Plasmodium parasite, we evaluated the
production of IL-2 and expression of the IL-2Rα-chain (CD25).
For this, we crossed transgenic OT-I mice (CD45.1+) with mice
that lack AT1R until the generation of homozygous OT-I mice
knockout in the Agtr1a gene (AT1R
−/− OT-I mice CD45.1+).
The specific response was tracked by adoptively transferring
naive WT (AT1R+/+) or AT1R
−/− OT-I cells into WT recipient
mice (CD45.2+) (Figure 1A). The recipient mice were infected
24 h later with 5 × 106 red blood cells infected with OVA-
PbA (Figure 1A). In parallel, mice that received WT OT-I cells
were treated with vehicle or 20mg/kg losartan, an AT1 receptor
antagonist, or 20 mg/kg captopril, an angiotensin-converting
enzyme inhibitor (Figure 2A).
Similar to our previous observations (Silva-Filho et al., 2016),
both losartan and captopril treatments inhibited the expansion
of OT-I cells (Figure 2B). In non-infected mice (naive), the non-
activated OT-1 cells do not proliferate and disappear over time
(Figure 2B), confirming that stimulation occurs in an antigen-
specific manner (Lundie et al., 2008; Miyakoda et al., 2008;
Silva-Filho et al., 2016). Six days after infection, when signs of
CM became evident (Martins et al., 2010), the percentage of
CD25+ cells and expression of CD25, determined by the median
fluorescence intensity (MFI), were 30 and 35% lower in the
AT1R
−/− OT-I cells, respectively (Figures 1B–D). In addition,
there was a 60% reduction in the amount of IL-2 produced by
re-stimulated AT1R
−/− OT-I cells in comparison with WT OT-I
cells (Figures 1E,F). Similar to AT1R
−/− OT-I cells, WT OT-
I cells harvested from infected mice treated with losartan or
captopril showed lower CD25 expression and IL-2 production
under re-stimulation (Figures 2C–F). These results confirm that
AT1R stimulates expansion of Plasmodium-specific CD8
+ T cells
during blood-stagemalaria as well as during radiation-attenuated
sporozoite immunization (Silva-Filho et al., 2016), and this effect
correlates with the upregulation of IL-2Rα expression and IL-2
production.
AT1R Is Involved in the Exacerbated
Activation of Plasmodium-specific CD8+ T
Cells during Blood-Stage Malaria
Next, we evaluated whether genetic and pharmacological
inhibition of AT1R affect the exacerbated activation of the effector
Plasmodium-specific CD8+ T cells induced by infection with
blood-stage Plasmodium parasite. Expression of the activation
and effector function markers CD69, CD160, CD44, and CD62L
were analyzed at day 6 post infection (p.i.).
The percentage and expression of CD69 were 35 and 33%
lower in AT1R
−/− OT-I cells than WT controls, respectively
(Figures 3A–C). Losartan and captopril treatments also
inhibited CD69 upregulation in WT OT-I cells (Figures 4A–C).
Upregulation of CD160 expression was inhibited 58% in
AT1R
−/− OT-I cells compared with the WT OT-I cells
(Figures 3D–F). In turn, WT OT-I cells harvested from
infected mice that received losartan or captopril treatment
showed a similar decrease in CD160 frequency and expression
(Figures 4D–F). We also verified a slight decrease in the
percentage of CD44+ AT1R
−/− OT-I cells (Figures 3G–I).
CD62L expression decreases in the effector population [40].
In this regard, CD62L expression is significantly lower in WT
OT-I cells (MFI, 48.6 ± 6.7) than in AT1R
−/− OT-I cells (MFI,
90.7 ± 8.7) (Figures 3J–L). WT OT-I cells exposed to losartan
or captopril treatment showed reduced CD44 expression and a
higher percentage of CD62L+ cells (Figures 4G–L). The reduced
clonal expansion and expression of activation markers in OT-I
cells lacking AT1R signaling reveal its influence in the priming
of Plasmodium-specific CD8+ T cells during the blood-stage of
PbA infection.
To make sure that functional antigen presentation, and then
T-cell activation, are not affected by WT or AT1R
−/− OT-I cells,
we analyzed endogenous CD8+ T cells, gated on CD8+CD45.1−
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FIGURE 3 | AT1R is a co-stimulatory receptor for activation of Plasmodium-specific CD8
+ T cells. Percentage of cells expressing the markers of activation
CD69, CD160, CD44, and CD62L were evaluated in WT and AT1R
−/− OT-I cells (CD8+CD45.1+) recovered from the spleen of mice (CD45.2+) infected with
OVA-PbA at day 6 p.i. The gating strategy used for the flow cytometry analysis is indicated in the Materials and Methods section. (A,B) Representative dot plots and
percentage of CD69+ OT-I cells among total OT-I cells in the spleen (*p = 0.0023). (C) Expression of CD69 was evaluated, based on MFI analysis, in WT and
AT1R
−/− OT-I cells (CD8+CD45.1+) recovered from the spleen of infected recipient mice (CD45.2+) at day 6 p.i. (*p = 0.0306). (D,E) Representative dot plots and
percentage of CD160+ OT-I cells among total OT-I cells in the spleen (*p < 0.0001). (F) Expression of CD160 was evaluated, based on MFI analysis, in WT and
AT1R
−/− OT-I cells (CD8+CD45.1+) recovered from the spleen of infected recipient mice (CD45.2+) at day 6 p.i. (*p < 0.0001). *In relation to WT OT-I cells. Data are
means ± SEM of five mice per group and are pooled from three independent experiments with similar results. (G,H) Representative dot plots and percentage of
CD44+ OT-I cells among total OT-I cells in the spleen (*p = 0.0031). (I) Expression of CD44 was evaluated, based on MFI analysis, in WT and AT1R
−/− OT-I cells
(CD8+CD45.1+) (p = 0.2405). (J,K) Representative dot plots and percentage of CD62L+ OT-I cells among total OT-I cells in the spleen (*p = 0.0007). (L) Expression
of CD62L was evaluated, based on MFI analysis, in WT and AT1R
−/− OT-I cells (CD8+CD45.1+) (*p = 0.0011). *In relation to WT OT-I cells. Data are means ± SEM
of five mice per group and are pooled from three independent experiments with similar results.
cells (Figure S1). As previously demonstrated (Miyakoda et al.,
2008), a lower but significant level of activation was detected
in non-OT-I CD8+ T cells (CD8+CD45.1−) from infected mice
in relation to cells from an uninfected host (naive) (Figure S2).
Importantly, changes in the expression of CD69, CD44, CD160,
and CD62L in these cells were similar in mice that received
eitherWT (WT→WT) or AT1R
−/− OT-I cells (AT1R
−/−→WT)
(Figure S2). These results confirm that WT and AT1R
−/− OT-I
cells respond in similar environments, where the presentation of
the parasite antigens is the same.
AT1R Induces Exhaustion of
Plasmodium-specific CD8+ T Cells during
the Blood-Stage Malaria
It is known that effector function of CD8+ T cells can be
reduced by increasing the expression of inhibitory receptors,
which are also referred to as markers of cellular exhaustion
(Baitsch et al., 2012; Legat et al., 2013). They are upregulated
during differentiation to effector cells and function as a
negative feedback mechanism. Thus, they are also used
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FIGURE 4 | Losartan and captopril treatments reduce activation of Plasmodium-specific CD8+ T cells. Percentage of cells expressing the markers of
activation CD69, CD160, CD44, and CD62L were evaluated at day 6 post infection in WT OT-I cells (CD8+CD45.1+) recovered from the spleen of recipient mice
(CD45.2+) infected with OVA-PbA and treated with vehicle, losartan (20 mg/kg/day) or captopril (20 mg/kg/day). The gating strategy used for the flow cytometry
analysis is indicated in the Materials and Methods section. (A–C) Representative dot plots, percentage of CD69+ OT-I cells among total OT-I cells in the spleen (*p <
0.0001), and expression of CD69 (*p = 0.0003). (D–F) Representative dot plots, percentage of CD160+ OT-I cells among total OT-I cells in the spleen (*p < 0.0001),
and expression of CD160 (*p = 0.0001). (G–I) Representative dot plots, percentage of CD44+ OT-I cells among total OT-I cells in the spleen (*p < 0.0001), and
expression of CD44 was evaluated (*p = 0.0112). (J–L) Representative dot plots, percentage of CD62L+ OT-I cells among total OT-I cells in the spleen (*p = 0.0047),
and expression of CD62L (p = 0.7873). *In relation to WT OT-I cells from infected mice treated with vehicle. Data are means ± SEM of five mice per group and are
pooled from three independent experiments with similar results.
for monitoring the status of activation and differentiation
of effector CD8+ T cells. Here, to better understand the
influence of AT1R in the activation and differentiation
of effector antigen-specific CD8+ T cells, we verified the
expression of the exhaustion markers CTLA-4, PD1, and LAG-3
(Scheipers and Reiser, 1998; Zha et al., 2004; Richter et al.,
2009).
Figures 5, 6 shows that, at day 6 p.i., the percentage and
expression of CTLA-4 and LAG-3 were lower in AT1R
−/− OT-
I cells and WT OT-I cells exposed to captopril treatment. In
contrast, in WT OT-I cells from mice infected treated with
losartan, only the frequency and expression of CTLA-4 were
reduced (Figure 6). PD-1 expression and frequency were not
changed in any OT-I cells lacking AT1R signaling (Figures 5, 6).
Thus, AT1R signaling in Plasmodium-specific CD8
+ T cells
promotes exhaustion of the responding population, along with
higher activation.
AT1R Upregulates Integrin and Chemokine
Receptors in Plasmodium-specific CD8+ T
Cells
Previously, we showed the key role of Ang II/AT1R axis
in the upregulation of CD11a, and the chemokine receptors
CCR2 and CCR5 in polyclonal T cells during the blood
stage of PbA infection (Silva-Filho et al., 2013). Here, we
tested whether AT1R expressed in Plasmodium-specific CD8
+
T cells modulates the expression of molecules involved in the
migration and sequestration of pathogenic CD8+ T cells in
inflamed tissues during severe malaria, such as LFA-1 (CD11a),
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FIGURE 5 | AT1R induces exhaustion of Plasmodium-specific CD8
+ T cells. The percentage of cells expressing exhaustion markers, PD-1, LAG-3, and
CTLA-4, were evaluated in WT and AT1R
−/− OT-I cells (CD8+CD45.1+) isolated from the spleen of mice (CD45.2+) infected with OVA-PbA at day 6 p.i. The gating
strategy used for the flow cytometry analysis is indicated in the Materials and Methods. (A–C) Representative dot plots, percentage of CTLA-4+ OT-I cells among total
OT-I cells in the spleen (*p < 0.0001), and expression of CTLA-4 (*p < 0.0001). (D–F) Representative dot plots, percentage of LAG-3+ OT-I cells among total OT-I
cells in the spleen (*p < 0.0001) and expression of LAG-3 (*p = 0.0018). (G–I) Representative dot plots, percentage of PD-1+ OT-I cells among total OT-I cells in the
spleen (p = 0.7826), and expression of PD-1 (p = 0.3596). *In relation to WT OT-I cells. Data are means ± SEM of five mice per group and are representative of three
independent experiments with similar results for each indicated time point.
CCR5, and CXCR3 (Falanga and Butcher, 1991; Belnoue,
2003; Sarfo et al., 2004; Hansen et al., 2007; Nie et al.,
2009).
Figure 7 shows that AT1R
−/− OT-I cells from mice infected
with OVA-PbA significantly express lower amounts of CD11a
(55% less), CCR5 (27% less), and CXCR3 (36% less) in relation to
WT controls. Losartan treatment inhibited only the upregulation
of CCR5 expression, whereas captopril inhibited the increase of
CCR5 and CXCR3 expression inWTOT-I cells (Figure 8). These
results imply that AT1R expressed in Plasmodium-specific CD8
+
T cells promotes the upregulation of CD11a and chemokine
receptors involved in the accumulation of these cells in inflamed
tissues during blood-stage malaria, which agrees with the
pathogenic role of AT1R during cerebral malaria (Silva-Filho
et al., 2016).
AT1R Stimulates Cytokine Production and
Degranulation by Plasmodium-specific
CD8+ T Cells during the Blood-Stage
Malaria
So far, AT1 receptor is important for a higher activation,
exhaustion, and expression of adhesion molecules/chemokine
receptors in Plasmodium-specific CD8+ T cells. Previously,
we showed that losartan and captopril impaired IFN-
γ, IL-17 by CD4+ T cells, and perforin production by
CD8+ T cells during PbA infection (Silva-Filho et al.,
2013). In addition, effector antigen-specific CD8+ T
cells lacking AT1R show lower polyfunctional capacity
(Silva-Filho et al., 2016). Then, we evaluated the specific
influence of AT1R in the production of cytokines and
degranulation by Plasmodium-specific CD8+ T cells after
ex-vivo stimulation with SIINFEKL-pulsed EL4 target
cells.
Analysis of CD107a, a lysosomal-associated membrane
protein associated with cytolytic granules that can be detected
on the surface of T cells following degranulation, showed
that degranulation was impaired in AT1R
−/− OT-I cells
(Figure 9A). Moreover, AT1R
−/− OT-I cells produce lower
amounts of IFN-γ and TNF-α (Figures 9C,E). Treatment
of infected mice with losartan or captopril only decreased
the production of TNF-α by the WT OT-I cells (Figure 9).
Together, our results show that Ang II, via AT1R, promotes
a harmful phenotype of Plasmodium-specific CD8+ T cells
during blood-stage malaria by inducing an exacerbated
effector response, represented by a higher activation, capacity
to migrate to inflamed tissues, cytokine production and
degranulation.
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FIGURE 6 | Losartan and captopril treatments reduce exhaustion of Plasmodium-specific CD8+ T cells. Percentage of cells expressing exhaustion
markers, PD-1, LAG-3, and CTLA-4, were evaluated in WT OT-I cells (CD8+CD45.1+) isolated from the spleen of recipient mice (CD45.2+) infected with OVA-PbA
and treated with vehicle, losartan (20 mg/kg/day), or captopril (20 mg/kg/day). The gating strategy used for the flow cytometry analysis is indicated in the Materials
and Methods section. (A–C) Representative dot plots, percentage of CTLA-4+ OT-I cells among total OT-I cells in the spleen (*p = 0.0012), and expression of CTLA-4
(*p = 0.0008). (D–F) Representative dot plots, percentage of LAG-3+ OT-I cells among total OT-I cells in the spleen (*p = 0.001), and expression of LAG-3 (*p =
0.0137). (G–I) Representative dot plots, percentage of PD-1+ OT-I cells among total OT-I cells in the spleen (p = 0.8294), and expression of PD-1 (p = 0.3413). *In
relation to WT OT-I cells from infected mice treated with vehicle. Data are means ± SEM of five mice per group and are representative of three independent
experiments with similar results for each indicated time point.
DISCUSSION
Accumulating evidences show that CD8+ T cells are the main
effector cells in the development of CM in murine models
(Boubou et al., 1999; Belnoue et al., 2002; Nitcheu et al., 2003;
Potter et al., 2006; Rénia et al., 2006; Suidan et al., 2008; Hunt
et al., 2010; Claser et al., 2011; Haque et al., 2011; Shaw et al.,
2015). It is known that Ang II binds to two different receptors,
AT1R and AT2R, but we verified that only AT1R is upregulated
in CD8+ T cells and mediates the effects of Ang II during
PbA infection (Silva-Filho et al., 2011, 2013, 2016). AT1R acts
as a co-stimulatory receptor for T-cell activation, promoting
perforin expression and sequestration of CD8+ T cells in the
brain, a cellular mechanism involved in cerebral edema and
behavioral impairment during the blood stage of PbA infection,
as well as in other models of diseases (Guzik et al., 2007; Platten
et al., 2009; Silva-Filho et al., 2011, 2013; Zhang et al., 2012).
In this work, using a transgenic parasite lineage expressing the
model antigen ovalbumin (OVA-PbA) (Miyakoda et al., 2008),
we further evaluated the role of AT1R expressed in blood-stage
Plasmodium-specific CD8+ T cells. We demonstrated that Ang
II/AT1R is a stimulatory axis for activation, exhaustion,migration
and effector function of Plasmodium-specific CD8+ T cells. These
observations suggest the role of AT1R in stimulating a harmful
CD8+ T-cell response that accelerates lethal CM (Silva-Filho
et al., 2013, 2016; Gallego-Delgado et al., 2016) and expand the
knowledge of the RAS in malaria pathogenesis.
Previous studies using transgenic lineages of parasites
expressing model epitope in combination with TCR transgenic
mice (Lundie et al., 2008; Miyakoda et al., 2008), revealed that
antigens of blood-stage P. berghei parasites are captured and
cross-presented by CD8α+ dendritic cells and stimulate antigen-
specific CD8+ T cells response (Lundie et al., 2008; Miyakoda
et al., 2008; Lau et al., 2011; Howland et al., 2013, 2015a).
In addition, highly activated parasite-specific CD8+ T cells are
sequestered in the brain and recognize antigens presented by
endothelial cells (Grau et al., 1991; Boubou et al., 1999; Engwerda
et al., 2002; Nitcheu et al., 2003; Potter et al., 2006; Suidan et al.,
2008; Claser et al., 2011; Haque et al., 2011; Shaw et al., 2015).
Recently, it was identified that Vβ8.1+ CD8+ T cells recognize
the H-2Db-restricted epitope SQLLNAKYL from glideosome-
associated protein 50 from PbA (Howland et al., 2013). These
cells are enriched in the brain during ECM (Boubou et al., 1999;
Belnoue et al., 2002) and they are able to damage the blood–
brain barrier and mediate CM (Howland et al., 2013, 2015a).
In human CM, because of ethical limitations, the key role of
CD8+ T cells in human disease is difficult to determine. However,
there is evidence that CD8+ T cells play an important role. In a
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FIGURE 7 | AT1R upregulates CD11a and chemokine receptors in Plasmodium-specific CD8
+ T cells during blood-stage PbA infection. The percentage
of cells expressing CD11a, CCR5, and CXCR3 was evaluated in WT and AT1R
−/− OT-I cells (CD8+CD45.1+) harvested from the spleen of recipient mice (CD45.2+)
infected with OVA-PbA and analyzed at day 6 p.i. The gating strategy used for the flow cytometry analysis is indicated in the Materials and Methods section. (A–C)
Representative dot plots, percentage of CD11a+ OT-I cells among total OT-I cells in the spleen (*p < 0.0001), and expression of CD11a (*p < 0.0001). (D–F)
Representative dot plots, percentage of CCR5+ OT-I cells among total OT-I cells in the spleen (*p = 0.0041) and expression of CCR5 (*p < 0.0001). (G–I)
Representative dot plots, percentage of CXCR3+ OT-I cells among total OT-I cells in the spleen (*p = 0.0004), and expression of CXCR3 (*p = 0.0001). *In relation to
WT OT-I cells. Data are means ± SEM of four mice per group and are representative of three independent experiments with similar results.
systematic post-mortem study of the brains of Malawian children
with CM, few CD8+ T cells were observed intravascularly in
distended capillaries (Dorovini-Zis et al., 2011), similar to mice
infected with PbA mouse, where the relatively small numbers of
sequestered CD8+ T cells are difficult to observe by histology
(Belnoue et al., 2002). CXCL10, whose primary function is to
mediate the migration of activated CD8+ T cells, has been
associated with CM. CXCL10 was the only biomarker quantified
in post-mortem serum, that was statistically different between
Ghanaian children who had died of CM vs. malarial anemia
(Armah et al., 2007). In Indian patients, high levels of CXCL10
were also associated with a higher risk of CM mortality (Jain
et al., 2008; Wilson et al., 2011). In addition, a single nucleotide
polymorphism in the CXCL10 gene promoter was associated
with increased gene expression and a higher risk of CM (Wilson
et al., 2013). The discovery of blood-stage P. falciparum MHC
class I epitopes would clarify whether pathogenic CD8+ T cells
are induced and important during human CM.
Here, using known pharmacological tools we confirmed that
AT1R is important for the clonal expansion of the effector
Plasmodium-specific CD8+ T cells during blood-stage malaria.
It has been demonstrated that IL-2 signaling is important for
CD8+ T-cell proliferation as shown in different models (Nataraj
et al., 1999; Inoue et al., 2006; D’Cruz et al., 2009). Thus, as
a correlated mechanism, we verified that AT1R increases IL-2R
expression and IL-2 production by parasite-specific CD8+ T cells.
This effect seems to involve Ang II-induced NADPH oxidase-
mediated reactive oxygen species generation and activation of
calcineurin phosphatase (Nataraj et al., 1999; Inoue et al., 2006).
In addition to expansion, AT1R has also been reported to
modulate T-cell activation (Nataraj et al., 1999; Guzik et al.,
2007; Jurewicz et al., 2007; Hoch et al., 2008; Platten et al.,
2009; Silva-Filho et al., 2011). Here we observed, using both
genetic and pharmacological approaches, that AT1R induces
higher activation and exhaustion of Plasmodium-specific CD8+
T cells during blood-stage malaria. The higher expression of
CD69 and CD44 in AT1R-sufficient OT-I cells indicates that
AT1R confers a higher capacity to respond to antigen, which
could contribute to the exhausted phenotype. This also could be
correlated with the higher IL-2 production by WT OT-I cells,
because CD69 signaling upregulates IL-2 expression via NFAT
and AP-1 transcription factors (D’Ambrosio et al., 1993). In turn,
CD160 expression increases in cells expressing high levels of
CD44 and producing more IFN-γ (Tsujimura et al., 2006). In
agreement, CD44 and CD160 are upregulated to a greater degree
in AT1R-sufficient CD8
+ T cells, which also produce higher
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FIGURE 8 | Losartan and captopril treatments reduce chemokine receptor expression in Plasmodium-specific CD8+ T cells. Percentage of cells
expressing CD11a, CCR5, and CXCR3 were evaluated in WT OT-I cells (CD8+CD45.1+) harvested from the spleen of recipient mice (CD45.2+) infected with
OVA-PbA and treated with vehicle, losartan (20 mg/kg/day), or captopril (20 mg/kg/day). The gating strategy used for the flow cytometry analysis is indicated in the
Materials and Methods section. (A–C) Representative dot plots, percentage of CD11a+ OT-I cells among total OT-I cells in the spleen (p = 0.1721), and expression of
CD11a (p = 0.7627). (D–F) Representative dot plots, percentage of CCR5+ OT-I cells among total OT-I cells in the spleen (*p = 0.0005), and expression of CCR5
(*p = 0.0001). (G–I) Representative dot plots, percentage of CXCR3+ OT-I cells among total OT-I cells in the spleen (*p = 0.0053), and expression of CXCR3
(*p = 0.0001). *In relation to WT OT-I cells from infected mice treated with vehicle. Data are means ± SEM of four mice per group and are representative of three
independent experiments with similar results.
amounts of IFN-γ. -γ. Along with the lower activation, there is
a lower percentage of AT1R-deficient OT-I cells expressing the
exhaustion molecules CTLA-4 and LAG-3. Usually, exhausted
T cells lose the ability to produce cytokines such as IL-2, IFN-
γ and TNF-α and to degranulate (Wherry and Kurachi, 2015).
Here, although AT1R
−/− OT-I cells are less exhausted, they
produce lower amounts of cytokines under re-stimulation. This
difference could be because AT1R
−/− OT-I cells are also less
activated.
We also demonstrated the importance of AT1R in CCR5
and CXCR3 upregulation in Plasmodium-specific CD8+ T cells.
This could correlate with the AT1R-induced migration and
sequestration of T cells into the brain microvasculature during
ECM (Silva-Filho et al., 2013; Howland et al., 2015a). In this
regard, CCR5 expression and their ligand RANTES/CCL5 are
upregulated in the brain of patients with CM (Sarfo et al., 2004).
In addition, in CCR5-deficient mice, there is a lower number of
CD8+ T cells accumulated in the cerebral microvasculature and
80% of mice are resistant to PbA-mediated ECM (Belnoue, 2003).
Another chemokine receptor involved in ECM pathogenesis
is the CXC chemokine receptor 3 (CXCR3) (Hansen et al.,
2007; Campanella et al., 2008; Miu et al., 2008; Van den
Steen et al., 2008; Nie et al., 2009). CXCR3 expression is
upregulated only in T cells from CM-susceptible but not CM-
resistant mice, indicating that CXCR3 expression correlates with
disease severity (Van den Steen et al., 2008). In agreement,
70–80% of CXCR3−/− mice are resistant to PbA-mediated
CM (Campanella et al., 2008; Miu et al., 2008). Thus, the
upregulation of the integrin LFA-1 (CD11a), and the chemokine
receptors CCR5 and CXCR3 in AT1R-sufficient Plasmodium-
specific CD8+ T cells could be the mechanisms involved in
AT1R-induced sequestration of CD8
+ T cells in the inflamed
tissues during ECM (Silva-Filho et al., 2013; Howland et al.,
2015a). The quality of the T-cell response, verified by the
ability to produce multiple cytokines and degranulate when in
contact with the target cell, is another important parameter
for consideration of the effector response (Sandberg et al.,
2001; Lichterfeld, 2004; Seder et al., 2008; Thiers, 2008). During
blood-stage malaria, degranulation of Granzyme B, perforin,
and exacerbated levels of proinflammatory cytokines such as
TNF-α and INF-γ are involved with the damage to the blood–
brain barrier (Grau et al., 1991; Boubou et al., 1999; Engwerda
et al., 2002; Nitcheu et al., 2003; Potter et al., 2006; Suidan
et al., 2008; Claser et al., 2011; Haque et al., 2011; Shaw et al.,
2015). Here, we verified that along with the higher activation
phenotype, WT OT-I cells produce higher amounts of IL-2,
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FIGURE 9 | AT1R promotes cytokine production and degranulation of effector Plasmodium-specific CD8
+ T cells. 1 × 104 naive WT or AT1R
−/−
CD45.1+ OT-I cells were adoptively transferred to WT C57BL/6 (CD45.2+) recipients 1 day before infection with 5 × 106 RBCs infected with OVA-PbA. WT OT-I cells
(CD8+CD45.1+) were also recovered from the spleen of mice infected with OVA-PbA (CD45.2+) treated with vehicle, losartan (20 mg/kg/day) or captopril (20
mg/kg/day). Six days post infection, cytokine production was evaluated after 4-h ex-vivo re-stimulation with SIINFEKL peptide-coated target cells. (A,B)
Representative dot plots of CD107a+ OT-I cells among total OT-I cells in the spleen. (C,D) Representative dot plots of IFN-γ+ OT-I cells among total OT-I cells in the
spleen. (E,F) Representative dot plots of TNF-α+ OT-I cells among total OT-I cells in the spleen. *p < 0.05 in relation to WT OT-I cells or WT OT-I cells from mice
treated with vehicle. Data are means ± SEM of four mice per group and are representative of three independent experiments with similar results.
TNF-α, and IFN-γ and degranulate in comparison to AT1R
−/−
OT-1 cells.
The present results are similar to previous studies showing
that Ang II, via AT1R, increases T-cell activation, differentiation
into effector cells, adhesion, and migration, leading to the
infiltration of T cells in different organs (Nataraj et al., 1999;
Inoue et al., 2006; Guzik et al., 2007; Jurewicz et al., 2007;
Crowley et al., 2008; Hoch et al., 2008; Platten et al., 2009;
Silva-Filho et al., 2011, 2013; Zhang et al., 2012). However,
it is important to highlight the observed contrasts between
the current findings and our results using immunization with
radiation-attenuated Plasmodium sporozoites (Silva-Filho et al.,
2016). For instance, CD69, CD160, CD44, LAG3, and CTLA-
4 expression on day 7 is unaffected in the absence of AT1R
following immunization (Silva-Filho et al., 2016), but here we
showed that the expression of these proteins is reduced by
day 6 following infection. These data suggest that there are
biologically important context-specific differences in the intrinsic
role of AT1R in CD8
+ T cells. Likewise, HO-1 plays distinct
roles at different stages of the Plasmodium life cycle. During
the liver stage, upregulation of HO-1 leads to an increase in
parasite liver load (Epiphanio et al., 2008), whereas in mice
injected with PbA-infected red blood cells, the establishment
of experimental CM is suppressed (Pamplona et al., 2007).
Malaria is a very complex disease, with multiple arms of immune
system working together and modulating one another. Thus,
intrinsic differences between the two experimental models, such
as the absolute expression level of the antigen, the location
and mechanisms of antigen presentation, are important factors
in determining antigen-specific immune responses that could
explain such discrepancies (Bagot et al., 2004; Lin et al., 2014).
In addition, divergences may also occur due to: (1) the life-
long deletion of AT1R in T cells might lead to compensatory
changes in other genes and related signals, modulating T-cell
populations or other properties of specific T cells; (2) AT1R
can exhibit dual signaling in which G-protein activation leads
to deleterious effects, whereas Gα(q) protein-independent/β-
arrestin–dependent pathways promote beneficial effects (Zhang
et al., 2012); (3) the AT1R can heterodimerize with other
angiotensin or bradykinin receptors, affecting downstream
signaling pathways. In addition, AT1R activates multiple
downstream signals important to induce pro-inflammatory
transcription factors, T-cell activation, proliferation, chemotaxis
and cytokine production (Sinclair et al., 2008; Smith-Garvin
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et al., 2009; Balakumar and Jagadeesh, 2014). However, the
AT1R-induced signaling pathways behind these processes are
not yet known. Thus, the predominance of a set of signaling
pathways induced by AT1R could diverge during the T-cell
response following different immune contexts. Future studies will
investigate how AT1R signaling leads to transcription of the T-
cell molecules following infection vs. immunization, which may
indicate additional levels of complexity in the role of AT1R in the
interplay between host and pathogen.
Previously, it was suggested that increased levels of Ang II
have a beneficial effect against malaria-induced pathology in
mouse models. A significant reduction in blood parasitemia
was observed in mice infected with PbA treated with a
supraphysiological concentration of Ang II (Gallego-Delgado
et al., 2015). A moderate reduction in the establishment of CM
and decreased incidence of brain hemorrhage followed by a
modest increase in survival were also verified (Gallego-Delgado
et al., 2015). Apparently, these results differ from the current
study and our previous works (Silva-Filho et al., 2013, 2016).
However, because Ang II is quicklymetabolized forming different
biologically active peptides, the amelioration of mice could be
attributed to increased levels of plasma Ang-(1–7) (Saraiva et al.,
2011; Silva et al., 2016a,b). Recently, the same group verified that
pharmacological blockade of the AT1R or stimulation of AT2R
protected mice against CM, reduced cerebral hemorrhages and
increased survival (Gallego-Delgado et al., 2016). In contrast,
AT2R-deficient mice were more susceptible to CM. In agreement
with this study and our previous works (Silva-Filho et al., 2013,
2016), these observations confirm that Ang II receptors could
influence the outcome of experimental CM; protection can be
achieved by blockade of AT1R or activation of AT2R, whereas
the opposite effect is observed by activation of AT1R when
AT2R is deleted. Thus, in response to infection during blood-
stage malaria, AT1R induces the formation of a larger effector
population of Plasmodium-specific CD8+ T cells with a higher
capacity to migrate to inflamed tissues, translated by the higher
expression of integrin and chemokine receptors, and higher
cytokine production. These observations show that inhibition
of AT1R signaling restricts Plasmodium-specific CD8
+ T-cell
function. In addition, because the level of antigen-specific T-cell
recruitment to the brain is governed largely by the magnitude
of splenic T-cell priming rather than by secondary differences in
brain-localized T-cell migratory cues (Lin et al., 2014; Howland
et al., 2015a), these data suggest how inhibition of AT1R could
increase the resistance of mice against CM, promoting survival,
improving cognitive parameters, and reducing cerebral edema
(Silva-Filho et al., 2013, 2016; Gallego-Delgado et al., 2016).
Together, these data bring new contributions to the mechanisms
involved in the pathogenic activity of CD8+ T cells during
the blood-stage of Plasmodium infection and to the functions
of the RAS in malaria pathogenesis. Repurposing of Ang II
modulators, such as AT1R antagonists or ACE inhibitors, as
adjunctive treatment for CM is a potential therapeutic possibility
(Silva-Filho et al., 2013; Gallego-Delgado et al., 2016; Silva et al.,
2016b).
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